Larimar Therapeutics
LRMR
#6457
Rank
A$0.88 B
Marketcap
$12.26
Share price
-12.17%
Change (1 day)
227.20%
Change (1 year)

EPS for Larimar Therapeutics (LRMR)

EPS in 2023 (TTM): -$1.39

According to Larimar Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.42. In 2022 the company made an earnings per share (EPS) of -$2.38 an increase over its 2021 EPS that were of -$4.58.

EPS history for Larimar Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.39-41.65%
2022-$2.38-48.15%
2021-$4.58-14.27%
2020-$5.35